Exact Mass: 243.9806316
Exact Mass Matches: 243.9806316
Found 370 metabolites which its exact mass value is equals to given mass value 243.9806316,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Apraclonidine
C9H10Cl2N4 (244.02824800000002)
Apraclonidine is only found in individuals that have used or taken this drug.Apraclonidine, also known as iopidine, is a sympathomimetic used in glaucoma therapy.Apraclonidine is a relatively selective alpha2 adrenergic receptor agonist that stimulates alpha1 receptors to a lesser extent. It has a peak ocular hypotensive effect occurring at two hours post-dosing. The exact mechanism of action is unknown, but fluorophotometric studies in animals and humans suggest that Apraclonidine has a dual mechanism of action by reducing aqueous humor production through the constriction of afferent ciliary process vessels, and increasing uveoscleral outflow. S - Sensory organs > S01 - Ophthalmologicals > S01E - Antiglaucoma preparations and miotics > S01EA - Sympathomimetics in glaucoma therapy C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists
2-Hydroxy-2-(hydroxymethyl)-3-oxo-4-phosphonooxybutanoic acid
p-Coumaric acid sulfate
p-Coumaric acid sulfate (CAS: 376374-66-2) is an endogenous phenolic acid metabolite. p-Coumaric acid sulfate was found to be elevated in rat urine after whole rye consumption which makes this compound a potential urinary biomarker of whole grain intake (PMID: 26862900). BioTransformer predicts that p-coumaric acid sulfate is a product of p-coumaric acid metabolism via a 4-O-sulfation-of-phenolic-compound reaction catalyzed by sulfotransferase 1A3 (P0DMM9) and sulfotransferase enzymes (PMID: 30612223).
(2E)-3-[3-(sulfooxy)phenyl]prop-2-enoic acid
(2e)-3-[3-(sulfooxy)phenyl]prop-2-enoic acid is a predicted metabolite generated by BioTransformer¹ that is produced by the metabolism of (2e)-3-(3-hydroxyphenyl)prop-2-enoic acid. It is generated by Sulfotransferase 1A3 (P0DMM9) and Sulfotransferase enzymes via a -3-O-sulfation-of-phenolic-compound reaction. This -3-O-sulfation-of-phenolic-compound occurs in humans.
4-chloro-3,4-dihydro-5,6,8-trihydroxy-3-methylisocoumarin
C10H9ClO5 (244.01384939999997)
3-(hydroxyprop-1-ynyl)-6-(5-hexen-3-yn-1-ynyl)-1,2-dithiacyclohexa-3,5-diene|4,7-Epidithio-4,6,12-tridecatriene-2,8,10-triyn-1-ol
Ketone-2,3-Dihydro-5-[[5-(1-propynyl)-2-thienyl]ethynyl]thiophen-3-ol
3-(1-propynyl)-6-(5-hexen-3-yn-1-ynyl)-cyclohexa-3,5-diene-1,2-thiosulphinate|Thiarubrin 1-oxide
3-(1-propynyl)-6-(5,6-epoxyhex-3-yn-1-ynyl)-1,2-dithiacyclohexa-3,5-diene|3-[4-(2-Oxiranyl)-1,3-butadiynyl]-6-(1-propynyl)-1,2-dithiin|thiarubrine D
8-Bromo-5-fluoro-2,3-dihydro-4H-chromen-4-one
C9H6BrFO2 (243.95351680000002)
1-(Difluoromethyl)-4-iodo-1H-pyrazole
C4H3F2IN2 (243.93090519999998)
(3-Bromophenyl)(tert-butyl)sulfane
C10H13BrS (243.99212780000002)
acetazolamide sodium
C471 - Enzyme Inhibitor > C29577 - Carbonic Anhydrase Inhibitor C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic
5-BROMO-2-CHLOROMETHYL-IMIDAZO[1,2-A]PYRIDINE
C8H6BrClN2 (243.94028459999998)
6-bromo-2-(chloromethyl)imidazo[1,2-a]pyridine
C8H6BrClN2 (243.94028459999998)
5-(5-Bromothiazol-2-yl)-1-methyl-1H-[1,2,4]triazole
3-(1H-Tetrazol-1-yl)benzenesulfonyl chloride
C7H5ClN4O2S (243.98217400000001)
(S)-(6-BROMO-2,3-DIHYDROBENZO[B][1,4]DIOXIN-2-YL)METHANOL
4-AMINO-N-CYCLOPROPYL-3,5-DICHLOROBENZAMIDE
C10H10Cl2N2O (244.01701500000001)
6-CHLORO-2-METHYL-1,2,3,4-TETRAHYDRO-1LAMBDA6-BENZOTHIINE-1,1,4-TRIONE
C10H9ClO3S (243.99609139999998)
3-(3,4-DICHLORO-PHENYL)-TETRAHYDRO-PYRAN-2-ONE
C11H10Cl2O2 (244.00578200000004)
N-((5-bromopyridin-3-yl)methyl)-2-methoxyethanamine
C9H13BrN2O (244.02111879999998)
3-AMINO-3-(5-CHLORO-2-NITRO-PHENYL)-PROPIONIC ACID
4-Chlorobenzenesulfonic acid but-3-ynyl ester
C10H9ClO3S (243.99609139999998)
3-BROMO-5-CHLORO-6-METHYL-7-AZAINDOLE
C8H6BrClN2 (243.94028459999998)
METHYL 4-ACETYL-3-METHYL-5-(METHYLTHIO)THIOPHENE-2-CARBOXYLATE
(2E)-3-(3-Bromo-4-fluorophenyl)acrylic acid
C9H6BrFO2 (243.95351680000002)
2,4-dichloro-6-(trifluoromethyl)phenylhydrazine
C7H5Cl2F3N2 (243.97818660000002)
1-bromo-2-(1,1-dimethoxyethyl)benzene
C10H13BrO2 (244.00988580000003)
4-(2-Bromoethyl)-1,2-dimethoxybenzene
C10H13BrO2 (244.00988580000003)
[3-(3-bromopropoxy)phenyl]methanol
C10H13BrO2 (244.00988580000003)
1-(3-bromo-5-fluorophenyl)-2-methylpropan-1-one
C10H10BrFO (243.98990019999997)
1-(Bromomethyl)-4-(trifluoromethyl)cyclohexane
C8H12BrF3 (244.00744079999998)
2,6-Dichloro-4-(trifluoromethyl)phenylhydrazine
C7H5Cl2F3N2 (243.97818660000002)
7-CHLORO-3-OXO-3,4-DIHYDRO-2H-PYRIDO[3,2-B][1,4]THIAZINE-6-CARBOXYLIC ACID
4-Bromo-1-(4-fluorophenyl)-1-butanone
C10H10BrFO (243.98990019999997)
[4-(3-bromopropoxy)phenyl]methanol
C10H13BrO2 (244.00988580000003)
1-Bromo-2-(3-methoxypropoxy)benzene
C10H13BrO2 (244.00988580000003)
2-AMINO-6-CHLORO-4,7-DIMETHOXYBENZOTHIAZOLE
C9H9ClN2O2S (244.00732440000002)
4-(2,2-Dichlorocyclopropyl)phenol 1-acetate
C11H10Cl2O2 (244.00578200000004)
1-Bromo-3-(2-methoxyethoxy)methylbenzene
C10H13BrO2 (244.00988580000003)
4-Bromo-2-chloro-1-methyl-1H-benzimidazole
C8H6BrClN2 (243.94028459999998)
(R)-(6-BROMO-2,3-DIHYDROBENZO[B][1,4]DIOXIN-2-YL)METHANOL
1-Bromo-4-[(2-methoxyethoxy)methyl]benzene
C10H13BrO2 (244.00988580000003)
2-CHLORO-4-(TRIFLUOROMETHYL)PYRIMIDINE-5-CARBONYL CHLORIDE
C6HCl2F3N2O (243.94180319999998)
4-Chloro-2-(4-oxo-piperidinyl)-5-thiazolecarboxaldehyde
C9H9ClN2O2S (244.00732440000002)
2,5-DIAMINO-1,4-BENZENEDITHIOL DIHYDROCHLORIDE
C6H10Cl2N2S2 (243.96624400000002)
[4-(trifluoromethyl)thiophen-2-yl]hydrazine,hydrochloride
C7H8ClF3N2S (244.00487939999996)
4-bromo-1-methoxy-2-propan-2-yloxybenzene
C10H13BrO2 (244.00988580000003)
4-(2H-Tetrazol-5-yl)benzenesulfonyl chloride
C7H5ClN4O2S (243.98217400000001)
2-Bromo-4-(dimethoxymethyl)-1-methylbenzene
C10H13BrO2 (244.00988580000003)
3-Chloro-6-methylbenzothiophene-2-carbonyl chloride
Tetraamminepalladium(II) dichloride
H12Cl2N4Pd (243.94737220000002)
4-Bromo-6-chloro-2-methyl-1H-benzo[d]imidazole
C8H6BrClN2 (243.94028459999998)
magnesium hypophosphite hexahydrate
C11H9NaO3S (244.01700839999998)
1-bromo-4-tert-butylsulfanylbenzene
C10H13BrS (243.99212780000002)
1,3,5-TRIMETHYL-1H-PYRAZOLE-4-SULFONYL CHLORIDE
C6H10Cl2N2O2S (243.98400200000003)
7-bromo-2-(chloromethyl)H-imidazo[1,2-a]pyridine
C8H6BrClN2 (243.94028459999998)
3-(3,4-dichlorophenyl)piperazin-2-one
C10H10Cl2N2O (244.01701500000001)
2-chloro-N-(6-fluoro-1,3-benzothiazol-2-yl)acetamide
1-Bromo-3-(3-methoxypropoxy)benzene
C10H13BrO2 (244.00988580000003)
3-bromo-5-tert-butylbenzene-1,2-diol
C10H13BrO2 (244.00988580000003)
4-fluoronaphthalene-1-sulfonyl chloride
C10H6ClFO2S (243.97610580000003)
2-Bromo-6-(3-methoxypropylamino)pyridine
C9H13BrN2O (244.02111879999998)
2-chloro-1-(2,3-dihydro-1,4-benzodithiin-6-yl)ethanone
C10H9ClOS2 (243.97833339999997)
3-Bromo-6-chloro-4-methyl-1H-pyrrolo[2,3-b]pyridine
C8H6BrClN2 (243.94028459999998)
3-Bromo-4-chloro-2-methyl-1H-pyrrolo[2,3-b]pyridine
C8H6BrClN2 (243.94028459999998)
1H-Pyrrolo[2,3-b]pyridine, 4-bromo-5-chloro-2-Methyl-
C8H6BrClN2 (243.94028459999998)
2,6-Dichloro-9-isopropyl-8-methyl-9H-purine
C9H10Cl2N4 (244.02824800000002)
2-[(4-chlorophenyl)sulfonyl]-2-hydroxyiminoacetonitrile
Methyl 2-(2,6-dichloro-3-cyanopyridin-4-yl)acetate
methyl 3-chloro-6-fluorobenzo(b)thiophe&
C10H6ClFO2S (243.97610580000003)
methyl 4,6-dichloro-1H-pyrrolo[3,2-c]pyridine-2-carboxylate
Arsonium,(2-hydroxyethyl)trimethyl-, bromide (1:1)
C5H14AsBrO (243.94439139999997)
2-Bromo-1-(4-fluorophenyl)-1-butanone
C10H10BrFO (243.98990019999997)
Domiodol
R - Respiratory system > R05 - Cough and cold preparations > R05C - Expectorants, excl. combinations with cough suppressants > R05CB - Mucolytics C78273 - Agent Affecting Respiratory System > C74536 - Mucolytic Agent
5,6-Dichloro-2-(3-hydroxypropyl)benzimidazole
C10H10Cl2N2O (244.01701500000001)
5-Bromo-2-chloro-4,6-dimethylnicotinonitrile
C8H6BrClN2 (243.94028459999998)
1H-Pyrrolo[2,3-b]pyridine-1-carboxylic acid, 4,6-dichloro-, methyl ester
(3-(3-CHLOROPHENYL)ISOXAZOL-5-YL)METHANAMINE HYDROCHLORIDE
C10H10Cl2N2O (244.01701500000001)
poassium 3-methoxyethylether phenyl trifluoroborate
3-Bromo-6-(methoxymethoxy)-o-xylene
C10H13BrO2 (244.00988580000003)
ethyl 4-(chlorocarbonothioyloxy)benzoate
C10H9ClO3S (243.99609139999998)
1-(difluoromethyl)-3,5-dimethylpyrazole-4-sulfonyl chloride
6-Fluoro-2-naphthalenesulfonyl chloride
C10H6ClFO2S (243.97610580000003)
1-(2-BROMOETHYL)-2,3,4,5,6-PENTAMETHYLBENZENE
C10H13BrO2 (244.00988580000003)
5-phenyl-thieno[2,3-d]pyrimidine-4-thiol
C12H8N2S2 (244.01288879999998)
1H-BENZIMIDAZOLE, 6-BROMO-2-(CHLOROMETHYL)-
C8H6BrClN2 (243.94028459999998)
3-AMINO-3-(4-CHLORO-3-NITRO-PHENYL)-PROPIONIC ACID
5,11-bisthio-(R,R)-1,7-diazatricyclo[7.3.0.07,11]dodecane-2,8-diketone
Iron,tricarbonyl[(1,2,3,4-h)-1,3,5,7-cyclooctatetraene]-
C11H8FeO3 (243.98228079999998)
(PHENYLSELENOMETHYL)TRIMETHYLSILANE
C10H16SeSi (244.01864259999996)
potassium (4-ethylthiophenyl)trifluoroborate
C8H9BF3KS (244.01071599999997)
1-Methyl-3-oxo-1,3-dihydro-benzo[c]isothiazole-5-sulfonic acid amide
Ferric nitrilotriacetate
D006401 - Hematologic Agents > D006397 - Hematinics > D005290 - Ferric Compounds D009676 - Noxae > D002273 - Carcinogens D009676 - Noxae > D009153 - Mutagens
2-{[(2-chloro-6-fluorophenyl)methyl]sulfanyl}-4,5-dihydro-1H-imidazole
C10H10ClFN2S (244.02372219999998)
Trisilane, 1,3-dichloro-1,1,2,2,3,3-hexamethyl-
C6H18Cl2Si3 (244.00933280000004)
(2-Hydroxypropyl)phenylarsinic acid
C9H13AsO3 (244.00806079999998)
alpha-oxo-1-carboxy-5,6-dihydrothiopyranpropanoate S-oxide
[Phosphonoamino-(2-sulfoethylamino)methylene]ammonium
[(2S,4S,5S)-4-hydroxy-5-(methylsulfanylmethyl)oxolan-2-yl] dihydrogen phosphate
2-(3-Pyridinyl)-4-thiophen-2-ylthiazole
C12H8N2S2 (244.01288879999998)
8-chloro-1-methyl-2,6-dioxo-7H-purine-3-carboxylic acid
[(2S,3S,4S,5S)-3,4,5,6-tetrahydroxyoxan-2-yl]methanesulfonic acid
[(2S,3S,4S,5S,6R)-3,4,5,6-tetrahydroxyoxan-2-yl]methanesulfonic acid
apraclonidine
C9H10Cl2N4 (244.02824800000002)
S - Sensory organs > S01 - Ophthalmologicals > S01E - Antiglaucoma preparations and miotics > S01EA - Sympathomimetics in glaucoma therapy C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists
6-deoxy-6-sulfo-D-fructofuranose
A carbohydrate sulfonate that is D-fructofuranose in which the hydroxy group at at position 6 is replaced by a sulfo group.
4-(sulfooxy)-cinnamic acid
An aryl sulfate that is (2E)-3-phenylprop-2-enoic acid which is substituted by a sulfooxy group at position 4. It is produced by the seagrass Zostera marina and has very promising antifouling potential against several micro- and macrofouling organisms.
3-(3-sulfooxyphenyl)propanoate(2-)
A 3-(3-sulfooxyphenyl)propanoic acid anion obtained by deprotonation of the carboxy and sulfo groups of 3-(3-sulfooxyphenyl)propanoic acid.
6-sulfo-beta-D-quinovose
A 6-sulfo-D-quinovose (6-deoxy-6-sulfo-D-glucopyranose) that has beta configuration at the anomeric centre.
6-sulfo-alpha-D-quinovose
A 6-sulfo-D-quinovose that has alpha configuration at the anomeric centre.
6-Sulfo-d-quinovose
A carbohydrate sulfonate that is D-quinovose (6-deoxy-D-glucose) in which one of the methyl hydrogens at position 6 is replaced by a sulfo group.
ZAPA (sulfate)
ZAPA sulfate is an agonist at low affinity GABAA-receptors. ZAPA sulfate induces membrane hyperpolarization of the Ascaris muscle cell with an EC50 of 10.3 μM[1][2].